tetano
Editor, Senior Moderator
Infect Dis (Auckl). 2020 Feb 6;13:1178633720904081. doi: 10.1177/1178633720904081. eCollection 2020. [h=1]Outcome of Critically Ill Patients With Influenza Infection: A Retrospective Study.[/h]
Abaziou T[SUP]1[/SUP], Delmas C[SUP]2[/SUP], Vardon Bounes F[SUP]1[/SUP], Bignon F[SUP]3[/SUP], Crognier L[SUP]1[/SUP], Seguin T[SUP]1[/SUP], Riu-Poulenc B[SUP]1[/SUP], Ruiz S[SUP]1[/SUP], Rouget A[SUP]1[/SUP], Cougot P[SUP]1[/SUP], Georges B[SUP]1[/SUP], Conil JM[SUP]1[/SUP], Minville V[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]Background:[/h] Influenza causes significant morbidity and mortality in adults, and numerous patients require intensive care unit (ICU) admission. Acute respiratory distress syndrome (ARDS) is clearly described in this context, but other clinical presentations exist that need to be assessed for incidence and outcome. The primary goal of this study was to describe the characteristics of patients admitted in ICU for influenza, their clinical presentation, and the 3-month mortality rate. The second objective was to search for 3-month mortality risk factors.
[h=4]Methods:[/h] This is a retrospective study including all patients admitted to 3 ICUs due to influenza-related disease between October 2013 and June 2016, which assesses the 3-month mortality rate. We compared clinical presentation, biological data, and outcome at 3 months between survivors and non-survivors. We created a predicting 3-month mortality model with Classification and Regression Tree analysis.
[h=4]Results:[/h] Sixty-nine patients were included, 50 patients (72.5%) for ARDS, 5 (7.2%) for myocarditis, and 14 (20.3%) for acute respiratory failure without ARDS criteria. Non-typed influenza A was found in 30 cases (43.5%), influenza A H1N1 in 18 (26.1%), H3N2 in 3 (4.3%), and influenza B in 18 cases (27.5%). The 3-month mortality rate was 29% (n = 20). Extracorporeal membrane oxygenation (ECMO) was implanted in 23 patients, without any significant increase in mortality (39% vs 24% without ECMO, P = .19). A creatinine serum superior to 96 μmol/L, an aspartate aminotransferase level superior to 68 UI/L, and a Pao[SUB]2[/SUB]/Fio[SUB]2[/SUB] ration below 110 were associated with 3-month mortality in our predictive mortality model.
[h=4]Conclusion:[/h] Influenza in ICUs may have several clinical presentations. The mortality rate is high, but ECMO may be an effective rescue therapy.
? The Author(s) 2020.
[h=4]KEYWORDS:[/h] ARDS; ECMO; ICU; Influenza; acute respiratory failure; myocarditis
PMID: 32082048 PMCID: PMC7005979 DOI: 10.1177/1178633720904081
Free PMC Article
Abaziou T[SUP]1[/SUP], Delmas C[SUP]2[/SUP], Vardon Bounes F[SUP]1[/SUP], Bignon F[SUP]3[/SUP], Crognier L[SUP]1[/SUP], Seguin T[SUP]1[/SUP], Riu-Poulenc B[SUP]1[/SUP], Ruiz S[SUP]1[/SUP], Rouget A[SUP]1[/SUP], Cougot P[SUP]1[/SUP], Georges B[SUP]1[/SUP], Conil JM[SUP]1[/SUP], Minville V[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]Background:[/h] Influenza causes significant morbidity and mortality in adults, and numerous patients require intensive care unit (ICU) admission. Acute respiratory distress syndrome (ARDS) is clearly described in this context, but other clinical presentations exist that need to be assessed for incidence and outcome. The primary goal of this study was to describe the characteristics of patients admitted in ICU for influenza, their clinical presentation, and the 3-month mortality rate. The second objective was to search for 3-month mortality risk factors.
[h=4]Methods:[/h] This is a retrospective study including all patients admitted to 3 ICUs due to influenza-related disease between October 2013 and June 2016, which assesses the 3-month mortality rate. We compared clinical presentation, biological data, and outcome at 3 months between survivors and non-survivors. We created a predicting 3-month mortality model with Classification and Regression Tree analysis.
[h=4]Results:[/h] Sixty-nine patients were included, 50 patients (72.5%) for ARDS, 5 (7.2%) for myocarditis, and 14 (20.3%) for acute respiratory failure without ARDS criteria. Non-typed influenza A was found in 30 cases (43.5%), influenza A H1N1 in 18 (26.1%), H3N2 in 3 (4.3%), and influenza B in 18 cases (27.5%). The 3-month mortality rate was 29% (n = 20). Extracorporeal membrane oxygenation (ECMO) was implanted in 23 patients, without any significant increase in mortality (39% vs 24% without ECMO, P = .19). A creatinine serum superior to 96 μmol/L, an aspartate aminotransferase level superior to 68 UI/L, and a Pao[SUB]2[/SUB]/Fio[SUB]2[/SUB] ration below 110 were associated with 3-month mortality in our predictive mortality model.
[h=4]Conclusion:[/h] Influenza in ICUs may have several clinical presentations. The mortality rate is high, but ECMO may be an effective rescue therapy.
? The Author(s) 2020.
[h=4]KEYWORDS:[/h] ARDS; ECMO; ICU; Influenza; acute respiratory failure; myocarditis
PMID: 32082048 PMCID: PMC7005979 DOI: 10.1177/1178633720904081
Free PMC Article